Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 2
2(40.0%)
N/A
2(40.0%)
Phase 1
1(20.0%)
5Total
Phase 2(2)
N/A(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT06672874Not ApplicableEnrolling By Invitation

Fermented Papaya and Driving Simulator Older Adult Study

Role: collaborator

NCT05191758Not ApplicableCompleted

Nutritional Regulation of Leukocyte Function

Role: collaborator

NCT02771366Phase 2Completed

The Efficient Brain Study

Role: collaborator

NCT01618045Completed

Nutritional Regulation of Wound Inflammation: Part II

Role: collaborator

NCT02332993Completed

Nutritional Regulation of Wound Inflammation: Part III

Role: collaborator

NCT02051634Phase 1Completed

Papaya Study ID:20140628

Role: collaborator

NCT01248143Phase 2Completed

Molecular and Clinical Effects of Green Tea and Fermented Papaya Preparation on Diabetes and Cardiovascular Diseases

Role: collaborator

All 7 trials loaded